@PhysInHistory Real analysis with its mapping to another space to solve intractable optimization problems that have dual equivalents in say Euclidean space
What detailed metabolomic analysis would say happens when you take omega-3?
-354 downstream FAs and oxylipins shift significantly.
-37 of the 354 (including EPA but not DHA levels) have significant associations with cardiovascular outcomes.
Learn more at https://t.co/bxHhrY2jVt
- In #VITAL trial, Lp(a)-C was NOT a/w increased CVD risk
- #Omega3 (1g/day EPA+DHA) vs placebo did NOT reduce Lp(a)-C levels (small increase of 4.2%)
Check out Dr. Zareen Farukhi’s oral abstract (Control No. 16471)
#AHA20@BrighamResearch@BWHDPM#cardiotwitter
Who would have thought that 1g of omega-3 a day leads to such profound changes in bioactive lipids and conventional downstream inflammatory and lipid biomarkers. We are continuing our work to get a more detailed picture of what it means for our health.
#MDPIMetabolites Randomized VITAL trial shows omega-3 treatment (EPA+DHA, 1 g/day) results in major changes in the plasma bioactive lipidome and red blood cell fatty acids compared with placebo
https://t.co/ZfgOXWODYN
#omega3@BrighamResearch@SamiaMoraMD@odemler
A pleasure working with @HarvardPhysics Dries Sels, Eugene Demler @odemler@Hesam_Dashti on NMR application for quantum computers!
Harvard researchers create hybrid algorithm for NMR readings https://t.co/hEOyYHiSoy via @Harvard#AI
HDL anti-inflammatory function: nonlinear relation with CV events in JUPITER Trial – having more HDL particles was protective only when HD was anti-inflammatory @JAHA_AHA#AHAJournals
Proud of your dedication & hard work @remiajalaMD#FIT@Odemler
https://t.co/uksTUeUps5